SHILPA MEDICARE
|
SHILPA MEDICARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 3.67 | -3.74 | 6.99 | 18.13 | 19.15 |
| CEPS(Rs) | 16.11 | 7.44 | 16.17 | 24.55 | 24.33 |
| DPS(Rs) | - | - | 1.10 | 1.10 | 1.10 |
| Book NAV/Share(Rs) | 208.37 | 205.44 | 209.93 | 181.37 | 163.06 |
| Tax Rate(%) | 41.19 | 19.24 | 40.76 | 25.04 | 17.81 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 20.50 | 8.41 | 17.21 | 19.05 | 23.63 |
| EBIT Margin(%) | 12.69 | 1.94 | 12.52 | 24.07 | 21.21 |
| Pre Tax Margin(%) | 4.72 | -3.65 | 8.93 | 21.65 | 20.71 |
| PAT Margin (%) | 2.77 | -2.94 | 5.29 | 16.22 | 17.02 |
| Cash Profit Margin (%) | 12.14 | 6.15 | 12.26 | 22.21 | 21.85 |
| Performance Ratios | |||||
| ROA(%) | 1.07 | -1.07 | 2.20 | 6.33 | 8.59 |
| ROE(%) | 1.78 | -1.71 | 3.67 | 10.41 | 12.23 |
| ROCE(%) | 5.49 | 0.80 | 5.94 | 10.73 | 12.38 |
| Asset Turnover(x) | 0.38 | 0.36 | 0.42 | 0.39 | 0.50 |
| Sales/Fixed Asset(x) | 0.61 | 0.59 | 0.73 | 0.75 | 0.99 |
| Working Capital/Sales(x) | 6.28 | -70.52 | 4.16 | 3.28 | 4.26 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.65 | 1.70 | 1.37 | 1.34 | 1.01 |
| Receivable days | 113.53 | 123.51 | 98.75 | 97.28 | 90.56 |
| Inventory Days | 105.35 | 117.32 | 109.68 | 113.34 | 83.24 |
| Payable days | 142.34 | 126.70 | 106.00 | 113.98 | 113.86 |
| Valuation Parameters | |||||
| PER(x) | 125.64 | - | 56.83 | 18.41 | 12.77 |
| PCE(x) | 28.64 | 30.83 | 24.56 | 13.59 | 10.05 |
| Price/Book(x) | 2.21 | 1.12 | 1.89 | 1.84 | 1.50 |
| Yield(%) | - | - | 0.28 | 0.33 | 0.45 |
| EV/Net Sales(x) | 4.26 | 2.63 | 3.57 | 3.82 | 2.58 |
| EV/Core EBITDA(x) | 19.44 | 23.11 | 18.78 | 16.25 | 9.88 |
| EV/EBIT(x) | 33.60 | 135.78 | 28.55 | 15.87 | 12.14 |
| EV/CE(x) | 1.79 | 1.07 | 1.64 | 1.48 | 1.36 |
| M Cap / Sales | 3.48 | 1.90 | 3.01 | 3.02 | 2.20 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 9.66 | -8.33 | 27.12 | -0.75 | 23.80 |
| Core EBITDA Growth(%) | 111.12 | -45.13 | 2.98 | -10.54 | 39.62 |
| EBIT Growth(%) | 617.39 | -85.80 | -33.88 | 12.62 | 38.22 |
| PAT Growth(%) | 203.36 | -151.03 | -58.56 | -5.41 | 41.15 |
| EPS Growth(%) | 198.15 | -153.54 | -61.45 | -5.36 | 39.10 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.52 | 0.45 | 0.37 | 0.57 | 0.29 |
| Current Ratio(x) | 1.26 | 0.98 | 1.45 | 1.47 | 1.52 |
| Quick Ratio(x) | 0.77 | 0.58 | 0.88 | 0.90 | 0.97 |
| Interest Cover(x) | 1.59 | 0.35 | 3.48 | 9.92 | 42.26 |
| Total Debt/Mcap(x) | 0.23 | 0.40 | 0.20 | 0.31 | 0.20 |
Compare Financial Ratios of peers of SHILPA MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHILPA MEDICARE | ₹7,162.4 Cr | -13.1% | -10.6% | 143.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
| CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics | |
SHILPA MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHILPA MEDICARE | -13.1% |
-10.6% |
143.5% |
| SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses
